Innovent Biologics Stock Market Value
| IVBXF Stock | USD 11.43 0.04 0.35% |
| Symbol | Innovent |
Innovent Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Innovent Biologics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Innovent Biologics.
| 04/23/2025 |
| 07/22/2025 |
If you would invest 0.00 in Innovent Biologics on April 23, 2025 and sell it all today you would earn a total of 0.00 from holding Innovent Biologics or generate 0.0% return on investment in Innovent Biologics over 90 days. Innovent Biologics is related to or competes with Alector, Context Therapeutics, Genmab AS, Iteos Therapeutics, Nutriband Warrant, Pulmatrix, and Theravance Biopharma. Innovent Biologics, Inc. operates as a biopharmaceutical company in China More
Innovent Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Innovent Biologics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Innovent Biologics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.12 | |||
| Information Ratio | 0.2088 | |||
| Maximum Drawdown | 28.71 | |||
| Value At Risk | (3.27) | |||
| Potential Upside | 12.67 |
Innovent Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Innovent Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Innovent Biologics' standard deviation. In reality, there are many statistical measures that can use Innovent Biologics historical prices to predict the future Innovent Biologics' volatility.| Risk Adjusted Performance | 0.2307 | |||
| Jensen Alpha | 1.11 | |||
| Total Risk Alpha | 0.442 | |||
| Sortino Ratio | 0.1983 | |||
| Treynor Ratio | 4.08 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Innovent Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Innovent Biologics Backtested Returns
Innovent Biologics is slightly risky given 3 months investment horizon. Innovent Biologics holds Efficiency (Sharpe) Ratio of 0.24, which attests that the entity had a 0.24 % return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.18% are justified by taking the suggested risk. Use Innovent Biologics Market Risk Adjusted Performance of 4.09, risk adjusted performance of 0.2307, and Downside Deviation of 5.12 to evaluate company specific risk that cannot be diversified away. Innovent Biologics holds a performance score of 18 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 0.28, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Innovent Biologics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Innovent Biologics is expected to be smaller as well. Use Innovent Biologics semi variance, and the relationship between the treynor ratio and daily balance of power , to analyze future returns on Innovent Biologics.
Auto-correlation | 0.54 |
Modest predictability
Innovent Biologics has modest predictability. Overlapping area represents the amount of predictability between Innovent Biologics time series from 23rd of April 2025 to 7th of June 2025 and 7th of June 2025 to 22nd of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Innovent Biologics price movement. The serial correlation of 0.54 indicates that about 54.0% of current Innovent Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.54 | |
| Spearman Rank Test | 0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.24 |
Innovent Biologics lagged returns against current returns
Autocorrelation, which is Innovent Biologics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Innovent Biologics' pink sheet expected returns. We can calculate the autocorrelation of Innovent Biologics returns to help us make a trade decision. For example, suppose you find that Innovent Biologics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Innovent Biologics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Innovent Biologics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Innovent Biologics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Innovent Biologics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Innovent Biologics Lagged Returns
When evaluating Innovent Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Innovent Biologics pink sheet have on its future price. Innovent Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Innovent Biologics autocorrelation shows the relationship between Innovent Biologics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Innovent Biologics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Innovent Pink Sheet
Innovent Biologics financial ratios help investors to determine whether Innovent Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Innovent with respect to the benefits of owning Innovent Biologics security.